iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Down 2.5% – Should You Sell?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shares fell 2.5% on Tuesday . The company traded as low as $19.88 and last traded at $19.98. 23,050 shares changed hands during trading, a decline of 23% from the average session volume of 30,046 shares. The stock had previously closed at $20.49.

iShares Genomics Immunology and Healthcare ETF Price Performance

The firm’s fifty day moving average is $22.24 and its two-hundred day moving average is $23.28. The firm has a market capitalization of $103.90 million, a PE ratio of 23.45 and a beta of 1.03.

Institutional Inflows and Outflows

An institutional investor recently raised its position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC lifted its holdings in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 180.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,650 shares of the company’s stock after purchasing an additional 17,150 shares during the period. Avior Wealth Management LLC owned about 0.46% of iShares Genomics Immunology and Healthcare ETF worth $603,000 at the end of the most recent reporting period.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.